Overview
- 4 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-03-11.
At a glance
Inspections
4
Sites
4
Observations
0
Career since
Jun 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| FUJIFILM Diosynth Biotechnologies Texas, LLC | 11 Mar 2025 | Human Drugs | On file |
| AbbVie Ireland NL. B.V. | 10 Sep 2024 | Human Drugs | On file |
| KBI Biopharma, Inc. | 18 Jun 2024 | Human Drugs | On file |
| KBI Biopharma, Inc. | 17 Jun 2024 | Human Drugs |
Sites inspected
FUJIFILM Diosynth Biotechnologies Texas, LLCCollege Station, United States1 insp.
AbbVie Ireland NL. B.V.Sligo, Ireland1 insp.
KBI Biopharma, Inc.Durham, United States1 insp.
KBI Biopharma, Inc.Durham, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Kamal N Tiwari2 shared
Olumide A Martins2 shared
Michael Shanks2 shared
Jie He1 shared
Zhong Li1 shared
Hamet M Toure1 shared
Full investigator report
Get the verbatim findings behind Ayyappan Rathakrishnan's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site